Subscribe Now!

Laurus Labs Ltd. –Story of Patience, diligence, and perseverance

-
 Laurus Labs Ltd. –Story of Patience, diligence, and perseverance
Twitter Handle: @shuchi_nahar

Result Update – Q3FY21
Laurus Lab performed extremely well consecutive in the 3rd quarter of FY21. The company did a robust growth in all three segments. Having  a healthy order book for FY 21 & beyond in FDF CMO business with a strategic partner in EU. Consolidated revenue for the quarter increased by 76% driven by growth in all the divisions.

The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 273 Crs. for the quarter. The generic API division recorded a healthy growth of over 100% for the quarter, the growth was led by higher growth in ARV API business in turn led by higher volume of 1st line products.

The Formulations business showcased a growth of over 120% for the 9M period, led by higher LMIC business. Custom Synthesis continues to maintain its growth trajectory with a healthy pipeline and with good visibility.

Capacity Expansion – To cater to future demands

Richcore will be renamed to Laurus Bio shortly. Laurus bio will able to cater the demands of food & fermentation and synergies are exciting for the same. With a vision of creating long term sustainable growth company continues to undertake major Capex program across all divisions.

Total Revenue from Operations came in at ₹ 1,288 crs, showcasing strong growth of 76% for the quarter and ₹ 3,402 crs for 9M FY21 growing by 71%. EBITDA Margins remained steady at 34% owing to better operating leverage and product mix.

PAT stood at ₹ 273 crs for the quarter, showcasing a robust growth of 274%. ROCE on an annualized basis has improved to 40%. The company continues to have a healthy cash position with ~ 600 crs of headroom available in the form of unutilized bank limits. The company continues to undertake larger CAPEX for all the divisions and initiate new manufacturing units on a greenfield basis.
Debt Scenario
3 Years Return Ratio

Business Highlights
Generic FDF.
  • Revenue growth of 47% for the quarter (Y-o-Y) and 121% for 9M (Y-o-Y). Generic FDF business maintains healthy growth momentum for the quarter. Commenced marketing of in-licensed products in the US by leveraging the front end. 
  • Contract manufacturing revenues from the EU region has a strong order book for FY21 and beyond.
  • 2 product validations completed for formulation apart from filling of 26 ANDAs & NDAs 9 products have received Final Approvals, and 8 products have received Tentative Approvals. Doubling their FDF capacity by FY22.
Synthesis & Ingredients.
  • Revenue showcased the growth of 63% for the quarter (Y-o-Y) and 45% for 9M (Y-o-Y). Total number of Active Projects in the CDMO division stood at 49 as of 9M FY21. 
  • State-of-the-art cGMP facilities to manufacture NCEs and Intermediates. Working with Large Global Innovator Pharmaceutical Companies, mid and small Biotech Companies.
Generic API.
  • Revenue from Generic API segment showcased the growth of 103% for the quarter (Yo-Y) and 52% for 9M (Y-o-Y).
  • The Anti-Viral segment showed robust growth of 165% for the quarter and 58% for 9M (Y-o-Y) and is expected to have good growth for the full year. Filed 282 patent applications and 141 patents granted as of Dec 31, 2020.
Laurus Bio Pvt. Ltd. – Briefing
  • Laurus Bio has 2 manufacturing facilities. The first one has a fermentation capacity of 10,750 Lts while the second one has 180,000 Lts (will be available by March 2021).
  • Laurus Bio/Richcore is an emerging biotech company.  Fast Growing Research Driven Bio - Manufacturing Company Recombinant products - animal origin free products for safer, viral free biomanufacturing.
  • Precision Fermentation capabilities -scale-up expertise and large scale manufacturing capabilities.
  • Strategic global partnerships for the commercialization of products.
15 Years of Patience, diligence & perseverance..
* Consolidated numbers based on certain assumptions 
** FY 21 numbers are as of 31st Dec 2020

Sources: Laurus Lab Investor Presentation Q3FY21 & Press Release

Disclaimer: The information provided on Shuchi Nahar’s Weekend Blog is for educational purposes only. The articles may contain external links, references, and a compilation of various publicly available articles. Hence all the authors are given due credit for the same. All copyrights and trademarks of images belong to their respective owners and are used for Fair Educational Purpose only.

Twitter Handle: @shuchi_nahar

Comments

Post a Comment

Most Favorite Reads!

Ethanol - Demand, Production, Opportunities & Production Projections (Part-2)

-
Image
Rapid Increase in Ethanol Production Capacity Twitter Handle: @shuchi_nahar Two Different types of processes  to produce Ethanol To produce 684 crore liters of ethanol by the sugar industry by 2025-26, sugarcane equivalent to 60 LMT of surplus sugar would be diverted to ethanol. In the current sugar season, 2020-21 more than 20 LMT of sugar is estimated to be diverted. To produce 666 crore liters of ethanol/ alcohol from food grains by 2025-26, about 165 LMT of food grains would be utilized. At present damaged food grain availability is around 40 lakh tons in the country. In 2020-21 approximately 20 lakh ton maize is surplus FCI Rice is also sufficient in stock (266 LMT) and it will continue to remain robust as procurement of paddy/rice at MSP continues at expected levels. The country is producing sufficient food grains and sugar to meet the requirement for ethanol. Molasses-based distilleries have also been offered interest subvention to convert them to dual feed, to convert b...
Read more

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-2)

-
Image
Ethanol production capacities, impact on Farmers, and Government Plans Twitter Handle: @shuchi_nahar Ethanol was rarely discussed in the country about 7-8 years ago. But now ethanol has become one of the major priorities of 21st century India. The focus on ethanol is having a better impact on the environment as well as on the lives of farmers. India’s requirement of ethanol for petrol blending will increase from 173 crore liters in 2019-20 to 1,016 crore liters in 2025-26. To enable the rollout of ethanol production across India, ethanol may be supplied from surplus to deficit states based on the requirements to ensure uniform availability of ethanol blends in the country. To achieve the Modi Administration’s E-20 blending goal by ethanol supply year (ESY) (December-November) 2025, India would need to procure approximately 11 billion liters (BL) of ethanol for blending with petroleum. As of November 2021, India’s concentrated ethanol production capacity totaled slightly above 6 bi...
Read more

Ethanol - Demand, Market Size, Opportunities & New Goverment Policies (Part-1)

-
Image
Ethanol - The next big tailwind story Twitter Handle: @shuchi_nahar Introduction Ethanol , also called ethyl alcohol, drinking alcohol, or simply alcohol is simple alcohol that is often abbreviated as EtOH. Ethanol production in India is mainly dominated by sugary feedstock, and C-heavy molasses available from sugar mills. Ethanol produced by fermentation of renewable food crops such as sugarcane, maize, wheat, sorghum, beet, and other starches is called bioethanol, and it is the eco-friendly alternative biofuel. The product is primarily used as a solvent in various industries such as: In addition, ethanol is gaining popularity as an efficient alternative fuel. It has significant penetration in the major end-use industries such as automotive, foods and beverages, chemicals, personal care and cosmetics, and pharmaceuticals. According to the reports, the global ethanol market is projected to grow at a robust CAGR of 4.5% to reach USD 117 Billion by the end of 2027. The primary factors fa...
Read more

Nutraceuticals - The Next Gem of Healthcare Sector

-
Image
     Nutraceuticals - The Next Gem of Healthcare Sector Shuchi.P.Nahar Twitter: shuchi_nahar What is Nutraceuticals? The term ‘nutraceuticals’ was firstly used in the late 1980s to describe food products that have a medicinal benefit. This fast-growing sector includes functional foods (such as vitamin-enriched products), nutritional supplements, sport drinks, and medically formulated foods.  Nutraceuticals and its Division Figure 1: The diagram showing the various divisions of Nutraceuticals  Scope Nutraceuticals is expected to play a central role in preventative healthcare. The logic seems simple - an ageing population gives rise to lifestyle-related diseases, whose impact can be lessened by making healthier choices earlier in life. This convergence of medicine, food and technology is likely to create a battleground in which food and pharma companies compete for dominance of the sector. Successful companies will have to hit the bullseye in six main areas: techn...
Read more

Laurus Labs - Result Update Q4FY21 & Full Year FY21

-
Image
Laurus Labs - Result Update Q4FY21 & Full Year FY21 Twitter Handle: @shuchi_nahar Laurus Labs Limited on 30th April 2021 announced its Q4FY21 and full-year results.  Laurus Lab performed extremely well consecutive in the 4th Quarter of FY21. The company did a robust growth in all three segments. Having a healthy order book for FY 22. Consolidated revenue for the quarter increased by 70% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 297 Crs. for the quarter. Generic API division showcased a robust growth of 61% YoY. Anti Viral segment recorded a robust growth of 70% YoY. Revenue Showcased a healthy growth of 102% YoY. The growth was led by higher LMIC Market volumes and increased volumes from North America and EU Commenced marketing of in-licensed products in the USA to leverage front-end capabilities. Custom Synthesis division recorded a strong growth of 35% YoY. Capacity Expan...
Read more